Search
Patexia Research
Case number 1:17-cv-01793

Neos Therapeutics, Inc. et al v. Teva Pharmaceuticals USA, Inc. > Documents

Date Field Doc. No.Description (Pages)
Jul 8, 2020 1 Complaint (6)
Jan 2, 2019 41 Patent/Trademark Report to Commissioner (1)
Jan 2, 2019 41 Main Document (1)
Docket Text: Report to the Commissioner of Patents and Trademarks for Patent/Trademark Number(s) 8,840,924 B2 ;9,072,680 B2 ;9,089,496 B2. (Attachments: # (1) Signed Stipulation and Order)(fms)
Jan 2, 2019 41 Signed Stipulation and Order (4)
Jan 2, 2019 40 Order (4)
Docket Text: ORDER re [39] Stipulation filed by Neos Therapeutics, LP, Neos Therapeutics, Inc., ***Civil Case Terminated. Signed by Judge Colm F. Connolly on 1/2/2019. (fms)
Dec 22, 2018 39 Stipulation (4)
Docket Text: STIPULATION and Order by Neos Therapeutics, Inc., Neos Therapeutics, LP. (Blumenfeld, Jack)
Dec 7, 2018 38 Stipulation to EXTEND Time (1)
Docket Text: STIPULATION TO EXTEND TIME for the Parties to Submit an Updated Joint Status Report to January 7, 2019 - filed by Teva Pharmaceuticals USA, Inc.. (Sharp, Melanie)
Dec 7, 2018 N/A SO ORDERED (0)
Docket Text: SO ORDERED, re [38] STIPULATION TO EXTEND TIME for the Parties to Submit an Updated Joint Status Report to January 7, 2019 filed by Teva Pharmaceuticals USA, Inc. Setting Deadlines: ( Status Report due by 1/7/2019.). Signed by Judge Colm F. Connolly on 12/7/2018. (fms)
Dec 6, 2018 N/A SO ORDERED (0)
Dec 6, 2018 N/A Oral Order (0)
Docket Text: ORAL ORDER re [35] Order Setting Teleconference: The teleconference set for 12/7/18 at 11:00 AM Eastern Time with Judge Thynge is cancelled. Ordered by Judge Mary Pat Thynge on 12/6/18. (cak)
Dec 5, 2018 36 Stipulation to EXTEND Time (1)
Docket Text: STIPULATION TO EXTEND TIME for Defendant to Serve its Initial Invalidity Contentions to December 30, 2018 - filed by Teva Pharmaceuticals USA, Inc.. (Higgins, James)
Nov 13, 2018 N/A Order Setting Teleconference (0)
Docket Text: ORAL ORDER Setting Teleconference: The teleconference set for 11/13/18 at 11:00 AM Eastern Time with Judge Thynge has been rescheduled for 12/7/2018 at 11:00 AM Eastern Time. Plaintiff's counsel to initiate the call. Ordered by Judge Mary Pat Thynge on 11/13/18. (cak)
Nov 7, 2018 N/A Oral Order (0)
Nov 7, 2018 34 Redacted Document (3)
Docket Text: REDACTED VERSION of [33] Status Report by Neos Therapeutics, Inc., Neos Therapeutics, LP. (Tigan, Jeremy)
Nov 6, 2018 N/A SO ORDERED (0)
Nov 5, 2018 32 Stipulation to EXTEND Time (2)
Docket Text: STIPULATION TO EXTEND TIME for Defendant to Serve its Initial Invalidity Contentions to December 6, 2018 - filed by Teva Pharmaceuticals USA, Inc.. (Higgins, James)
Oct 30, 2018 N/A Oral Order (0)
Oct 25, 2018 N/A Order Setting Teleconference (0)
Oct 23, 2018 30 Stipulation to EXTEND Time (1)
Docket Text: STIPULATION TO EXTEND TIME for Defendant to Serve Initial Invalidity Contentions to November 7, 2018 - filed by Teva Pharmaceuticals USA, Inc.. (Higgins, James)
Oct 23, 2018 N/A SO ORDERED (0)
Oct 16, 2018 N/A SO ORDERED (0)
Oct 15, 2018 29 Stipulation to EXTEND Time (2)
Docket Text: STIPULATION TO EXTEND TIME for Defendant to serve inital invalidity contentions to October 24, 2018 - filed by Teva Pharmaceuticals USA, Inc.. (Sharp, Melanie)
Sep 24, 2018 N/A Order Setting Teleconference (0)
Sep 20, 2018 N/A Case Reassigned to CFC (0)
Docket Text: Case reassigned to Judge Colm F. Connolly. Please include the initials of the Judge (CFC) after the case number on all documents filed. (jcs)
Sep 17, 2018 27 Notice of Service (2)
Docket Text: NOTICE OF SERVICE of Plaintiffs' Initial Infringement Claim Charts filed by Neos Therapeutics, Inc., Neos Therapeutics, LP.(Tigan, Jeremy)
Aug 24, 2018 N/A Oral Order (0)
Jul 27, 2018 N/A Oral Order (0)
Jul 19, 2018 24 Notice of Service (2)
Docket Text: NOTICE OF SERVICE of Plaintiffs' Paragraph 4(a) Disclosures filed by Neos Therapeutics, Inc., Neos Therapeutics, LP.(Tigan, Jeremy)
Jul 9, 2018 22 Notice of Service (2)
Docket Text: NOTICE OF SERVICE of Plaintiffs' Initial Disclosures Pursuant to Paragraph 3 of the Default Standard for Discovery filed by Neos Therapeutics, Inc., Neos Therapeutics, LP.(Tigan, Jeremy)
Jul 9, 2018 23 Notice of Service (2)
Docket Text: NOTICE OF SERVICE of Teva Pharmaceuticals USA, Inc.'s Initial Disclosures Under Paragraph 3 of the Default Standard for Discovery filed by Teva Pharmaceuticals USA, Inc..(Higgins, James)
Jun 20, 2018 20 Proposed Order (2)
Docket Text: PROPOSED ORDER -- Stipulated ADR Scheduling Order -- by Neos Therapeutics, Inc., Neos Therapeutics, LP. (Blumenfeld, Jack)
Jun 20, 2018 21 SO ORDERED (2)
Docket Text: SO ORDERED re [20] Proposed Order filed by Neos Therapeutics, LP, Neos Therapeutics, Inc. Signed by Judge Mary Pat Thynge on 6/20/18. (cak)
Jun 14, 2018 N/A Order Setting Teleconference (0)
May 21, 2018 N/A Order Setting Teleconference (0)
Apr 24, 2018 17 Order Setting Teleconference (4)
Docket Text: ORDER Setting Teleconference: Plaintiffs' counsel to initiate the call. A Telephone Conference is set for 5/18/2018 at 11:30 AM Eastern Time before Judge Mary Pat Thynge to discuss ADR. Signed by Judge Mary Pat Thynge on 4/24/18. (cak)
Apr 19, 2018 N/A Case Referred to Mediation (0)
Docket Text: CASE REFERRED to Chief Magistrate Judge Mary Pat Thynge for Mediation. Please see Standing Order dated January 20, 2016, regarding disclosure of confidential ADR communications. A link to the standing order is provided here for your convenience at http://www.ded.uscourts.gov/general-orders/magistrate-judges-standing-order-adr-mediation (cak)
Apr 5, 2018 N/A Oral Order (0)
Mar 15, 2018 16 Notice of Service (3)
Docket Text: NOTICE OF SERVICE of Plaintiffs' Initial Disclosures Pursuant to Federal Rule of Civil Procedure 26(a)(1) filed by Neos Therapeutics, Inc., Neos Therapeutics, LP.(Tigan, Jeremy)
Mar 15, 2018 15 Notice of Service (2)
Docket Text: NOTICE OF SERVICE of Teva Pharmaceuticals USA, Inc. Rule 26(a)(1) Initial Disclosures filed by Teva Pharmaceuticals USA, Inc..(Higgins, James)
Mar 5, 2018 14 Status Report (9)
Mar 5, 2018 14 Proposed Scheduling Order (5)
Mar 5, 2018 14 Main Document (9)
Docket Text: Joint STATUS REPORT by Neos Therapeutics, Inc., Neos Therapeutics, LP. (Attachments: # (1) Proposed Scheduling Order)(Tigan, Jeremy)
Feb 21, 2018 13 Answer to Counterclaim (12)
Docket Text: ANSWER to [8] Answer to Complaint, Counterclaim by Neos Therapeutics, Inc., Neos Therapeutics, LP.(Tigan, Jeremy)
Feb 9, 2018 N/A Add Attorneys Pro Hac Vice (0)
Docket Text: Pro Hac Vice Attorney Alison S. Cooney for Teva Pharmaceuticals USA, Inc. added for electronic noticing. Pursuant to Local Rule 83.5 (d)., Delaware counsel shall be the registered users of CM/ECF and shall be required to file all papers. (ceg)
Feb 8, 2018 N/A Add Attorneys Pro Hac Vice (0)
Feb 5, 2018 12 Order (2)
Docket Text: ORDER REGARDING CASE MANAGEMENT IN CIVIL CASES. Signed by Judge Gregory M. Sleet on 2/5/2018. (asw)
Feb 1, 2018 N/A SO ORDERED (0)
Feb 1, 2018 11 Order (2)
Docket Text: ORDER REGARDING CASE MANAGEMENT IN CIVIL CASES. Signed by Judge Gregory M. Sleet on 2/1/2018. (asw)
Jan 31, 2018 10 Motion for Leave to Appear Pro Hac Vice (5)
Docket Text: MOTION for Pro Hac Vice Appearance of Attorney Alison S. Cooney, Michael K. Nutter, Eric J. Shinabarger, and Kevin E. Warner - filed by Teva Pharmaceuticals USA, Inc.. (Sharp, Melanie)
Jan 31, 2018 9 Disclosure Statement (1)
Docket Text: Disclosure Statement pursuant to Rule 7.1: identifying Corporate Parent Teva Pharmaceutical Industries Ltd. for Teva Pharmaceuticals USA, Inc. filed by Teva Pharmaceuticals USA, Inc.. (Sharp, Melanie)
Jan 31, 2018 8 Answer to Complaint (18)
Docket Text: ANSWER to [1] Complaint, , COUNTERCLAIM against All Plaintiffs by Teva Pharmaceuticals USA, Inc..(Sharp, Melanie)
Jan 2, 2018 N/A SO ORDERED (0)
Dec 29, 2017 7 Stipulation to EXTEND Time (2)
Docket Text: STIPULATION TO EXTEND TIME to answer, move or otherwise respond to the Complaint to January 31, 2018 - filed by Teva Pharmaceuticals USA, Inc.. (Sharp, Melanie)
Dec 20, 2017 N/A Case Assigned/Reassigned (0)
Docket Text: Case Assigned to Judge Gregory M. Sleet. Please include the initials of the Judge (GMS) after the case number on all documents filed. (rjb)
Dec 14, 2017 6 Summons Returned Executed (2)
Docket Text: SUMMONS Returned Executed by Neos Therapeutics, LP, Neos Therapeutics, Inc.. Teva Pharmaceuticals USA, Inc. served on 12/14/2017, answer due 1/4/2018. (Tigan, Jeremy)
Dec 14, 2017 N/A Summons Issued (0)
Docket Text: Summons Issued with Magistrate Consent Notice attached as to Teva Pharmaceuticals USA, Inc. on 12/14/2017. Requesting party or attorney should pick up issued summons at the Help Desk, Room 4209, or call 302-573-6170 and ask the Clerk to mail the summons to them. (fms)
Dec 13, 2017 5 Disclosure Statement (1)
Docket Text: Disclosure Statement pursuant to Rule 7.1: identifying Other Affiliate Neos Therapeutics, Inc., Other Affiliate PharmaFab, Texas, LLC. for Neos Therapeutics, LP filed by Neos Therapeutics, Inc., Neos Therapeutics, LP. (fms)
Dec 13, 2017 4 Patent/Trademark Report to Commissioner (1)
Docket Text: Report to the Commissioner of Patents and Trademarks for Patent/Trademark Number(s) 8,840,924 B2; 9,072,680 B2; 9,089,496 B2;. (fms)
Dec 13, 2017 3 ANDA Form (1)
Docket Text: Supplemental information for patent cases involving an Abbreviated New Drug Application (ANDA) - Date Patentee(s) Received Notice: 10/31/2017. Date of Expiration of Patent: See attached.Thirty Month Stay Deadline: 4/30/2020. (fms)
Dec 13, 2017 2 Magistrate Consent Forms (3)
Docket Text: Notice, Consent and Referral forms re: U.S. Magistrate Judge jurisdiction. (fms)
Dec 13, 2017 1 Civil Cover Sheet (1)
Dec 13, 2017 1 Main Document (6)
Docket Text: COMPLAINT FOR PATENT INFRINGEMENT filed against Teva Pharmaceuticals USA, Inc. - Magistrate Consent Notice to Pltf. ( Filing fee $ 400, receipt number 0311-2284148.) - filed by Neos Therapeutics, LP, Neos Therapeutics, Inc. (Attachments: # (1) Exhibits A-C, # (2) Civil Cover Sheet)(fms)
Dec 13, 2017 1 Exhibits A-C (191)
Dec 13, 2017 1 Complaint* (1)
Menu